Including Funding rounds, Bull / Bear thesis, Stock + earnings, Roster changes, Patents, News, and Open roles.
Already subscribed? Sign in →
No articles ingested yet for Galvani Bioelectronics. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
Implantable vagus nerve stimulation system designed to modulate immune and metabolic pathways to treat chronic inflammatory diseases including rheumatoid arthritis, inflammatory bowel disease, and diabetes — without systemic drugs. The device delivers precisely calibrated electrical pulses to the vagus nerve trunk, exploiting the inflammatory reflex arc to suppress cytokine production. Backed jointly by GSK (55%) and Alphabet's Verily (45%); in active clinical programs targeting autoimmune and metabolic indications.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗